Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Arrowhead Pharmaceuticals’ phase 1/2a study has found the company’s investigational RNA interference (RNAi) candidate was ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...

Bybit, the world's second-largest cryptocurrency exchange by trading volume, announced an exclusive opportunity for USDT ...

Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm), today announced it is joining the ...

Here in the Arrowhead, dozens of people have been thrown out of their jobs, and hundreds more have been told they’re next. These are hardworking friends and neighbors doing critical work in our ...

With U.S. President Donald Trump’s tariffs targeting imported pharmaceuticals, headaches lie ahead for both American patients and Canadian companies and their workers, industry experts in Canada ...

President Irfaan Ali yesterday oversaw the execution of two Memoranda of Understanding (MoUs) – including one on pharmaceutical services – on the sidelines of the 48th Regular Meeting of ...